Global /Taiwan /Healthcare /Medical Devices /4171

GeneReach Biotechnology Corp.

4171

• TPEX: 4171 • Delayed

19.20TWD -0.5%

0.6072 USD

As of 14 June 2026, GeneReach Biotechnology Corp. has a market cap of $35.02M USD, ranking #33146 globally and #2025 in Taiwan. It ranks #2992 in the Healthcare sector, and #627 in the Medical Devices industry.

Global Rank

33146

Country Rank

2025

Sector Rank

2992

Industry Rank

627

Key Stats

Market Cap

$35.02MUSD

1.11B TWD

Enterprise Value

$33.06MUSD

1.05B TWD

Revenue (TTM)

$7.37MUSD

232.74M TWD

EBITDA (TTM)

-$703.29KUSD

-22.24M TWD

Net Income (TTM)

-$3.49MUSD

-110.28M TWD

EBITDA Margin

-9.6%

Profit Margin

-47%

PS Ratio

4.8

PB Ratio

1.9

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Medical Devices

CEO

De Yu Zhong open_in_new

Founded

2004

Website

genereach.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.5%	-6.6%	3.5%	-14%	-27%	2.4%	-4.2%	-59%	-77%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	4171 瑞基海洋生物科技股份有限公司 ISIN: TW0004171004 Shares Out.: Shares Outstanding: 57.303M¹ Shares Float: 35.203M² TV: TradingView: TPEX: 4171 SA: Stock Analysis: TPEX: 4171 YF: Yahoo Finance: 4171.TWO GF: Google Finance: TPEX: 4171 BA: Barron's: 4171 MS: Morningstar: ROCO: 4171	19.20 TWD	TV: TradingView: TPEX: 4171 SA: Stock Analysis: TPEX: 4171 YF: Yahoo Finance: 4171.TWO GF: Google Finance: TPEX: 4171 BA: Barron's: 4171 MS: Morningstar: ROCO: 4171

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About GeneReach Biotechnology Corp.

GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers various equipment, such as POCKIT Central Nucleic Acid Analyzer, POCKIT Micro Series, taco mini Automatic Nucleic Acid Extraction System, taco Prep Homogenization System, and cubee Mini-Centrifuge; reagents and consumables, including Human IVD Assays, iiPCR Specific Reagents, research reagents and consumables, as well as taco Nucleic Acid Extraction Reagents, IQ REAL Quantitative System, and IQ2000 Detection & Prevention System. It also provides training program; and other services comprising molecular diagnostic technical solutions and laboratory installation, OEM/ODM contract manufacturing, and research collaborations services. The company was founded in 2004 and is headquartered in Taichung, Taiwan.

Similar Companies

Industry: Medical Devices (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Sunmax Biotechnology Co., Ltd. TPEX: 4728	$668.26M 21.1B TWD 2K%	29.1	Taiwan
TaiDoc Technology Corp. TWSE: 4736	$377.5M 11.92B TWD 978%	8.3	Taiwan
YD Bio Ltd. NASDAQ: YDES	$364.92M 942%	-	Taiwan
United Orthopedic Corp. TPEX: 4129	$302.31M 9.55B TWD 763%	17.5	Taiwan
Bioteque Corp. TPEX: 4107	$254.54M 8.04B TWD 627%	15.0	Taiwan
Hi-Clearance Inc. TPEX: 1788	$191.02M 6.03B TWD 445%	16.4	Taiwan

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 495K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 459K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 454K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 361K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 345K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 291K%	22.2	Ireland

chevron_leftBack